Impact of mixed electrolyte imbalances at admission on adverse outcomes in patients with and without renal disease
Lists
Only you see this
Abstract
To the Editor: Kidney plays a pivotal role in maintaining electrolyte balance, which is essential for the normal functioning of many metabolic and physiological processes. Electrolyte imbalances (EIs) are common manifestations of renal dysfunction and can have potentially life-threatening consequences. Mixed EIs—the simultaneous presence of two or more EIs in a single patient—are frequently encountered in nephrology practice. Previous studies have typically treated different EIs as separate entities and explored their independent associations with prognosis. However, the combined prognostic impact of coexisting EIs remains unclear. This gap in knowledge underscores the urgent need for a comprehensive understanding of mixed EIs, especially in patients with renal disease (RD), where electrolyte dysregulation is both a pathological hallmark and a critical focus of treatment. This study aimed to investigate the prevalence and risk of adverse outcomes associated with different EI combinations in patients with and without RD. Approval was obtained from the Ethics Committee of Peking Union Medical College Hospital (No. K3719), and the requirement for informed consent was waived due to the use of anonymized clinical data. Inpatient medical records from January 1, 2015 to August 11, 2020 at Peking Union Medical College Hospital were screened. The exclusion criteria were as follows: (1) patients younger than 18 years old; (2) unclear discharge status; and (3) lack of serum sodium, potassium, calcium, or chloride measurements within 24 hours of admission. Finally, 271,127 hospitalizations involving 206,847 patients were enrolled in the analysis [Supplementary Figure 1, https://links.lww.com/CM9/C501]. Patient diagnoses, coded according to the International Classification of Diseases, 10th Revision, were extracted from electronic medical records to identify RD and non-RD groups. Based on these diagnoses, Charlson Comorbidity Index (CCI) was further calculated as a measure of the overall comorbidity burden. Serum electrolyte concentrations were defined as laboratory measurements obtained within 24 hours of hospital admission. For patients with hyperglycemia, serum sodium levels were corrected using the following formula: corrected sodium (mmol/L) = serum sodium (mmol/L) + 2.4 × (glucose [mmol/L] − 5.5)/5.5. Serum calcium was corrected for concomitant albumin as follows: corrected calcium (mmol/L) = serum calcium (mmol/L) + 0.02 × (40 − albumin [g/L]). This study adopted the following reference ranges: sodium, 135–145 mmol/L; potassium, 3.5–5.5 mmol/L; calcium, 2.13–2.70 mmol/L; and chloride, 96–111 mmol/L. Values below or above these reference ranges were considered as hypo- or hyper-EIs, respectively. A total of 8 EI types were included: hyponatremia (LNa), hypernatremia (HNa), hypokalemia (LK), hyperkalemia (HK), hypocalcemia (LCa), hypercalcemia (HCa), hypochloremia (LCl), and hyperchloremia (HCl). The number of distinct EI types present at admission was classified into 3 groups: 0 EI, 1 EI, and ≥2 EIs. Based on the 8 EI types, a total of 28 pair-wise EI combinations were identified. Given the high mortality rate in patients discharged against medical advice (AMA), adverse outcomes were defined as in-hospital mortality and AMA discharge. For continuous variables, mean ± standard deviation was used to describe normally distributed data, while median (1st quartile–3rd quartile) was utilized for non-normally distributed data. Categorical variables were presented as frequency (percentage). Group differences were compared using Student’s T test, Wilcoxon’s test, or chi-squared test. Multivariate Cox proportional hazards regression models were employed to estimate the association between number of EIs and adverse outcomes, with an examination of the interaction between RD status and number of EIs. The models were adjusted for age, gender, CCI, myocardial infarction, congestive heart failure, peripheral vascular disease, central vascular disease, diabetes mellitus, chronic lung disease, and moderate to severe liver disease. If a patient has multiple hospitalizations, these records are correlated and cannot be treated as independent observations. Therefore, patient ID was included as a random effect in the model to account for within-subject correlation and improve model accuracy. When assessing the association between a specific EI combination and adverse outcomes, the models were additionally adjusted for all other EI types. A two-tailed P -value <0.05 was considered statistically significant. To address multiple comparisons involving the 28 EI combinations identified in this study, Bonferroni correction was applied to the 95% confidence intervals (CIs). All analyses were carried out using R software (version 4.2.3; R Foundation for Statistical Computing, Vienna, Austria). Of all hospitalizations included, the median (1st quartile–3rd quartile) of age was 53 (39–64) years; 42.6% (115,551/271,127) were male; and 5.7% (15,450/271,127) had RD. The prevalence of admission mixed EIs escalated from 3.9% (9914/255,677, non-RD) to 16.0% (2473/15,450, RD), paralleling a 10-fold elevation in adverse outcomes (0.7% [1694/255,677] vs. 7.0% [1081/15,450], P <0.001) [Supplementary Table 1, https://links.lww.com/CM9/C501]. Compared to patients without EIs, those with 1 EI at admission had an increased risk of adverse outcomes, with a hazard ratio (HR) of 1.96 (95% CI: 1.64–2.33) in the RD group and 2.68 (95% CI: 2.37–3.02) in the non-RD group. For patients with ≥ 2 EIs, the risk was even higher, with an HR of 4.69 (95% CI: 3.98–5.53) in the RD group and 6.23 (95% CI: 5.51–7.06) in the non-RD group. A significant interaction was observed between number of EIs and RD status (interaction P <0.001) [Supplementary Table 2, https://links.lww.com/CM9/C501]. Among hospitalized patients with RD, LCl-LNa (3.7% [566/15,450]), HCl-HNa (2.6% [404/15,450]), and LK-LCa (2.6% [400/15,450]) were the top three most common EI combinations at admission [Supplementary Figure 2A and Supplementary Table 3, https://links.lww.com/CM9/C501]. Among hospitalized patients without RD, LK-LCa (1.2% [3185/255,677]), LCl-LNa (1.0% [2648/255,677]), and LK-LNa (0.7% [1832/255,677]) were the top three most common EI combinations at admission [Supplementary Figure 2B and Supplementary Table 3, https://links.lww.com/CM9/C501]. Among hospitalized patients without RD, HK-HNa (HR = 33.81 [95% CI: 8.09–141.34]), HCa-HNa (HR = 12.09 [95% CI: 3.78–38.71]), and HCl-HNa (HR = 8.57 [95% CI: 5.79–12.68]) were the top three high-risk EI combinations at admission [Figure 1A and Supplementary Table 3, https://links.lww.com/CM9/C501]. Among hospitalized patients with RD, HK-HNa (HR = 13.53 [95% CI: 5.86–31.23]), HCa-HNa (HR = 12.56 [95% CI: 6.44–24.51]), and LCa-HNa (HR = 11.32 [95% CI: 7.41–17.28]) were the top three high-risk EI combinations at admission [Figure 1B and Supplementary Table 3, https://links.lww.com/CM9/C501].Figure 1: Top 10 EI combinations most strongly associated with adverse outcomes among patients with and without RD. HRs and Bonferroni-corrected 95% CIs are shown for the 10 highest-risk EI combinations, ranked by descending point estimates: (A) patients without RD; (B) patients with RD. The reference group included hospitalizations without the specific EI combination. Adjusted for age, gender, Charlson comorbidity index, myocardial infarction, congestive heart failure, peripheral vascular disease, central vascular disease, diabetes mellitus, chronic lung disease, moderate to severe liver disease, and all other EI types. CI: Confidence interval; EI: Electrolyte imbalance; HCa: Hypercalcemia; HCl: Hyperchloremia; HK: Hyperkalemia; HNa: Hypernatremia; HR: Hazard ratio; LCa: Hypocalcemia; LCl: Hypochloremia; LK: Hypokalemia; LNa: Hyponatremia; RD: Renal disease.This large-scale retrospective cohort study demonstrated that mixed EIs are common among hospitalized patients, with a particularly high prevalence observed in those with RD. Notably, the association between EIs and adverse outcomes was also evident in patients without RD, indicating the broad clinical relevance of this relationship.[1] There are two potential explanations for this association. First, EIs may serve as indirect markers for the severity of underlying diseases; second, EIs may directly contribute to mortality by inducing organ dysfunction. Our findings further support the latter hypothesis: even after adjusting for comorbidities and other confounding factors, a higher number of EIs at admission remained significantly associated with increased risk of adverse outcomes. These results emphasize the importance of baseline electrolyte screening as part of risk stratification in hospitalized patients. Interestingly, the negative prognostic impact of EIs is more pronounced in the non-RD group. This renal paradox—simultaneously predisposing to EIs yet mitigating their lethality—may be partially explained by the enhanced nephrology surveillance and standardized electrolyte management. Consistent with the existing literature, while hypo-EIs are relatively common, hyper-EIs are associated with disproportionately worse outcomes.[2] This finding implies that hyper-EIs, which arise from water deprivation or solute overload, pose more harmful physiological disruptions. The combination of hypernatremia with hyperkalemia or hypercalcemia is particularly concerning. Hyperkalemia frequently occurs in patients with chronic kidney disease, diabetes, cardiovascular diseases, or those on renin–angiotensin–aldosterone system inhibitors. Elevated potassium levels can lead to life-threatening arrhythmias, such as ventricular tachycardia or fibrillation, by disrupting the heart’s electrical impulses.[3] Hypercalcemia, often stemming from primary hyperparathyroidism or malignancy, can lead to multiple complications, including renal insufficiency, cardiac arrhythmias, vascular calcification, hypercoagulability, altered mental status, and even coma.[4] Lastly, hypernatremia, caused by excess water loss or sodium gain can induce severe neurological injuries via brain volume reduction, vascular rupture, and demyelination.[5] Although the precise mechanisms remain unclear, the coexistence of these hyper-EIs may collectively exacerbate the harmful effects on health. To be noteworthy, the negative prognostic impact is most pronounced for EI combinations involving hypernatremia. This phenomenon suggests that sodium, as the principal cation in extracellular fluid, plays a crucial role in maintaining osmotic balance across body compartments, as well as in supporting normal cellular function and survival. Patients with RD are particularly vulnerable to hypernatremia due to their kidneys’ diminished capacity to concentrate urine.[6] Thus, we recommend heightened attention to patients with high-risk EI combinations upon admission. For individuals prone to such combinations, early recognition and prompt treatment during hospitalization may be crucial. This is a comprehensive study to provide an overview of mixed EIs among hospitalized patients. Our findings highlight the high prevalence and negative prognostic impact of mixed EIs at admission, emphasizing the clinical significance of this condition. While RD increases susceptibility to EIs, their risks for adverse outcomes appear to be lower. The identification of high-risk EI combinations by RD status will aid in baseline risk stratification and guide more personalized electrolyte management. However, further research is required to explore the underlying mechanisms of co-occurring EIs, which will enable more targeted preventive strategies. Funding This work was supported by the grants from Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (No. 2024-I2M-C&T-B-011) and National College Student Innovation and Entrepreneurship Training Program (No. 2023zglc06001). Conflicts of interest None. Data sharing The datasets analyzed during the current study are available from the corresponding author upon reasonable request.
BibTeX
@inproceedings{jiang2025impact,
author = {Nan Jiang and Hanze Du and Hongbo Yang and Huijuan Zhu and Shi Chen and Hui Pan},
title = {{Impact of mixed electrolyte imbalances at admission on adverse outcomes in patients with and without renal disease}},
booktitle = {Chinese},
year = {2025},
doi = {10.1097/cm9.0000000000003686},
}Loading related content...